Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment
BrainStorm Cell Therapeutics has just announced that they have completed enrollment in their Phase 3 clinical trial for amyotrophic lateral sclerosis (ALS). Enrollment was initiated way back in October of…